Thermo Fisher Scientific (NYSE: TMO) insider plans sale of 6,912 shares

Rhea-AI Filing Summary

Thermo Fisher Scientific insider plans NYSE sale of option shares. A holder has filed a notice to sell 6,912 shares of Thermo Fisher Scientific common stock on the NYSE through Fidelity Brokerage Services. The shares were acquired on 12/02/2025 via the cash exercise of a stock option originally granted on 02/26/2019. Based on the filing, the aggregate market value of the planned sale is $4,022,369.28. The filing also notes that 375,708,059 common shares were outstanding and that the same seller disposed of 6,913 common shares on 12/01/2025 for gross proceeds of $4,131,761.84.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6912	4022369.28	375708059	12/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/02/2025	Option Granted - 02/26/2019	Issuer			6912	12/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Frederick M. Lowery 168 Third Avenue Waltham MA 02451	Common	12/01/2025	6913	4131761.84

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Thermo Fisher Scientific's (TMO) latest Form 144 filing disclose?

The Form 144 filing discloses an insider's intent to sell 6,912 shares of Thermo Fisher Scientific common stock on the NYSE, following acquisition of those shares through a stock option exercise.

How many Thermo Fisher Scientific (TMO) shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 6,912 common shares of Thermo Fisher Scientific stock.

What is the reported market value of the Thermo Fisher (TMO) shares to be sold?

The aggregate market value of the 6,912 shares to be sold is listed as $4,022,369.28.

How and when were the Thermo Fisher (TMO) shares in the Form 144 acquired?

The shares were acquired on 12/02/2025 through a cash exercise of a stock option that was originally granted on 02/26/2019.

Has the Thermo Fisher (TMO) insider sold other shares recently?

Yes. The filing reports that the same seller disposed of 6,913 common shares on 12/01/2025 for gross proceeds of $4,131,761.84 during the past three months.

How many Thermo Fisher Scientific (TMO) shares were outstanding according to the Form 144?

The filing states that 375,708,059 common shares of Thermo Fisher Scientific were outstanding.